Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibody for the detection of the antiretroviral drug emtricitabine (FTC, 2′,3′-dideoxy-5-fluoro-3′-thiacytidine)

Monoclonal antibody for the detection of the antiretroviral drug emtricitabine (FTC, 2′,3′-dideoxy-5-fluoro-3′-thiacytidine)

US Patent 11186651 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HIV post-exposure prophylaxis2021
Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral 2020
Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral 2020
Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral 2019
Inhibition of HIV infection through chemoprophylaxis2019
Inhibition of HIV infection through chemoprophylaxis2018
Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral 2018
Serologic correlates of protection against Bacillus anthracis infection2017
Serologic correlates of protection against bacillus anthracis infection2017
Inhibition of HIV infection through chemoprophyalxis2017
Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral 2016
Primate T-lymphotropic viruses2016